Mycetoma: An Update
暂无分享,去创建一个
V. Garg | P. Agarwal | V. Relhan | K. Mahajan
[1] M. Goodfellow,et al. Mycetoma: a unique neglected tropical disease. , 2016, The Lancet. Infectious diseases.
[2] A. Fahal,et al. Eumycetoma and actinomycetoma – an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] G. S. de Hoog,et al. Madurella mycetomatis Is Highly Susceptible to Ravuconazole , 2014, PLoS neglected tropical diseases.
[4] J. Meis,et al. In Vitro Antifungal Activity of Isavuconazole against Madurella mycetomatis , 2012, Antimicrobial Agents and Chemotherapy.
[5] A. van Belkum,et al. Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents , 2010, Antimicrobial Agents and Chemotherapy.
[6] A. Fahal,et al. Mycetoma in children in Sudan. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] S. Tolat,et al. Modified Welsh regimen: a promising therapy for actinomycetoma. , 2008, Journal of drugs in dermatology : JDD.
[8] A. Bonifaz,et al. Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases , 2008, The British journal of dermatology.
[9] M. Mcginnis,et al. Subcutaneous Fungal Infections (Chromoblastomycosis, Mycetoma, and Lobomycosis) , 2008 .
[10] C. Linton,et al. Molecular identification of pathogenic fungi. , 2008, The Journal of antimicrobial chemotherapy.
[11] A. Zarei Mahmoudabadi,et al. Mycetomas in Iran: a review article , 2008, Mycopathologia.
[12] Vinod K. Sharma,et al. A modified two-step treatment for actinomycetoma. , 2007, Indian journal of dermatology, venereology and leprology.
[13] M. Augenbraun,et al. Mycetoma fungal infection: multiple organisms as colonizers or pathogens? , 2007, Revista da Sociedade Brasileira de Medicina Tropical.
[14] F. Dromer,et al. Molecular Identification of Black-Grain Mycetoma Agents , 2006, Journal of Clinical Microbiology.
[15] P. Massip,et al. Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[16] M. Dieng,et al. Clinical efficacy and safety of oral terbinafine in fungal mycetoma , 2006, International journal of dermatology.
[17] R. Negroni,et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. , 2005, Revista do Instituto de Medicina Tropical de Sao Paulo.
[18] S. Tyring,et al. Tropical dermatology: fungal tropical diseases. , 2004, Journal of the American Academy of Dermatology.
[19] R. López-martínez,et al. Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones , 1995, Mycopathologia.
[20] M. Salinas-Carmona,et al. Humoral Immunity through Immunoglobulin M Protects Mice from an Experimental Actinomycetoma Infection by Nocardia brasiliensis , 2004, Infection and Immunity.
[21] A. van Belkum,et al. In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H- Tetrazolium Hydroxide (XTT) Assay , 2004, Antimicrobial Agents and Chemotherapy.
[22] A. Fahal. Mycetoma: a thorn in the flesh. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[23] U. Hemal,et al. Pulse Therapy with Amikacin and Dapsone for the Treatment of Actinomycotic Foot: A Case Report , 2003, The Journal of dermatology.
[24] I. Sarris,et al. MRI of mycetoma of the foot: two cases demonstrating the dot-in-circle sign , 2003, Skeletal Radiology.
[25] M-T Dieng,et al. [Mycetoma: 130 cases]. , 2003, Annales de dermatologie et de venereologie.
[26] J. Graybill,et al. Subcutaneous mycoses. , 2003, Infectious disease clinics of North America.
[27] S. Bandyopadhyay,et al. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal , 2002, Tropical medicine & international health : TM & IH.
[28] M. L. Khatri,et al. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study , 2002, International journal of dermatology.
[29] A. Bonifaz,et al. Perianal actinomycetoma experience of 20 cases , 2002, International journal of dermatology.
[30] B. Veress,et al. The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[31] D. Haas,et al. MR and other imaging methods in the investigation of mycetomas. , 2001, Acta radiologica.
[32] M. Ramam,et al. A two-step schedule for the treatment of actinomycotic mycetomas. , 2000, Acta dermato-venereologica.
[33] A. van Belkum,et al. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. , 1999, Journal of clinical microbiology.
[34] A. Chaiprasert,et al. Deep fungal and higher bacterial skin infections in Thailand: clinical manifestations and treatment regimens , 1999, International journal of dermatology.
[35] P. Maiti,et al. Antibiotic sensitivity patterns of actinomycetes isolated from patients of actinomycetoma. , 1997, The Indian journal of medical research.
[36] M. C. Salinas,et al. Treatment of eumycetoma and actinomycetoma. , 1995, Current topics in medical mycology.
[37] A. Fahal,et al. The host tissue reaction to Madurella mycetomatis: new classification. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[38] M. Salinas-Carmona,et al. Enzyme-linked immunosorbent assay for serological diagnosis of Nocardia brasiliensis and clinical correlation with mycetoma infections , 1993, Journal of clinical microbiology.
[39] P. V. Venugopal,et al. TREATMENT OF EUMYCETOMA WITH KETOCONAZOLE , 1993, The Australasian journal of dermatology.
[40] A. Gómez,et al. AMOXICILLIN AND CLAVULANIC ACID IN THE TREATMENT OF ACTINOMYCETOMA , 1993, International journal of dermatology.
[41] P. Lavalle,et al. [Epidemiology of mycetoma in Mexico: study of 2105 cases]. , 1992, Gaceta medica de Mexico.
[42] O. Welsh,et al. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. , 1987, Journal of the American Academy of Dermatology.
[43] L. M. Alves,et al. Studies on the pathogenesis of actinomycotic mycetoma in animals injected with fractions isolated from Nocardia brasiliensis. , 1987, British journal of experimental pathology.
[44] R. Hay,et al. Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[45] E. Mahgoub,et al. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[46] R. Hay,et al. Mycetoma (madura foot) in the United Kingdom–a survey of forty‐four cases , 1983, Clinical and experimental dermatology.
[47] R. Rogers,et al. Diagnosis and treatment of mycetoma. , 1982, Journal of the American Academy of Dermatology.
[48] H. Gugnani,et al. Actinomycetoma in Nigeria. , 1981, The Journal of tropical medicine and hygiene.
[49] S. Subramanian,et al. MYCETOMA CAUSED BY MADURELLA MYCETOMII IN MADRAS , 1978, The Australasian journal of dermatology.
[50] E. Mahgoub. Medical management of mycetoma. , 1976, Bulletin of the World Health Organization.
[51] A. E. El Hassan,et al. Lymph node involvement in mycetoma. , 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[52] W. O. Green,et al. MYCETOMA IN THE UNITED STATES; A REVIEW AND REPORT OF SEVEN ADDITIONAL CASES. , 1964, American journal of clinical pathology.
[53] R. G. Archibald,et al. A Sudanese Maduromycosis , 1916 .